|
1. |
Absence of Cross-Reactivity to Myeloperoxidase of Anti-Thyroid Microsomal Antibodies in Patients with Autoimmune Thyroid Diseases |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 109-112
Beatriz Freire,
Ingrid Paula,
Francisco Paula,
Cees . Kallenberg,
Pieter Limburg,
Thais Queluz,
Preview
|
PDF (94KB)
|
|
摘要:
Background:Thyroperoxidase is the major antigen of the thyroid microsomal antibodies (TMA) detected in autoimmune thyroid diseases. Its amino acid sequence has 44% homology with myeloperoxidase (MPO), an enzyme present in the primary granules of neutrophils and one of the major antineutrophil cytoplasmic antibodies (ANCA) antigens. The objective of the present study was to investigate the presence of cross-reactivity to MPO of TMA.Methods:We studied sera from 51 patients with autoimmune thyroid diseases, all of them TMA-positive. The presence of ANCA was investigated by indirect immunofluorescence and by capture enzyme-linked immunosorbent assay.Results:ANCA were positive in 3.9% of the TMA-positive sera and none of them reacted with MPO. In contrast, the ANCA-positive sera revealed antielastase activity. None of the ANCA-positive cases presented clinical signs of vasculitis. However, these 2 patients had been on prolonged treatment with propylthiouracil.Conclusions:We conclude that there is no cross-reactivity to MPO of TMA in patients with autoimmune thyroid diseases, possibly because of difference in the spatial configuration of the immunodominant region. The presence of ANCA in patients with autoimmune thyroid diseases without evidence of vasculitis might result from propylthiouracil-induced polyclonal activation.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
2. |
Reversible Sequestration of Nitric Oxide by Hemoglobin During Hemodialysis in End-Stage Renal Disease |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 113-123
Ellen Kang,
Don Miles,
Marjorie Tevlin,
Taylor Cates,
Sergio Acchiardo,
Preview
|
PDF (180KB)
|
|
摘要:
Background:During hemodialysis, patients whose plasma concentrations of nitric oxide (NO) products increase reportedly experience hypotension. Therefore, whether NO bound to hemoglobin (Hb) could contribute to various clinical and laboratory changes during hemodialysis was explored in patients with end-stage renal disease (ESRD).Methods:Ten patients were studied during 3 hemodialysis treatments with samples of blood analyzed for RBC nitrosyl Hb (HbNO), l-arginine, asymmetric dimethylarginine (ADMA), plasma nitrite+nitrate (NOx), and buffy coat NO synthase (NOS) activities.Results:HbNO before and during hemodialysis varied considerably. Those with higher predialysis levels had lower HbNO values during dialysis, whereas HbNO levels in those with lower levels before dialysis increased. Plasma NOx did not correlate with HbNO, but change in HbNO in the first hour and change in NOx in the first 2 hours correlated with drop in diastolic and systolic blood pressures (BP), respectively. HbNO concentrations increased in patients with >35% drop in systolic BP, whereas in those with <35% drop, HbNO concentrations decreased. HbNO levels adjusted by the hematocrit showed a drop in HbNO for the <35% group and a >3-fold increase in the >35% group. HbNO levels were higher in men than in women, and levels and changes correlated with the hematocrit, skin temperatures, plasma ADMA, arginine, and buffy coat NOS.Conclusions:In patients with >35% drop in systolic BP, NO was scavenged by Hb in the circulating RBCs, undoubtedly attenuating the degree of hypotension. These data indicate that the amount of NO that is scavenged or released by Hb in the circulating RBCS during dialysis is highly variable and reversible. Various predialysis factors relate to the concentration of HbNO before and during dialysis, which in turn influence clinical findings that occur during the interdialytic period.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
3. |
Acute Respiratory Distress Syndrome as a Major Clinical Manifestation of Thrombotic Thrombocytopenic Purpura |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 124-128
Jae Chang,
El-Sayed Aly,
Preview
|
PDF (97KB)
|
|
摘要:
Background:Although the classical triad of thrombocytopenia, microangiopathic hemolytic anemia, and neurological changes has been well recognized, thrombotic thrombocytopenic purpura (TTP) sometimes presents with atypical clinical features. Some cases of acute respiratory distress syndrome (ARDS) were suspected to be a manifestation of TTP.Methods:We examined retrospectively the medical records of patients with known TTP from 1981 to 1998. The patients who developed ARDS simultaneously with TTP were identified. Clinical, laboratory, and other pertinent data were reviewed; the clinical outcome was documented.Results:Seven out of 56 patients with an established diagnosis of TTP were identified as having ARDS. All 7 patients had progressive dyspnea, persistent hypoxemia with diffuse pulmonary infiltrates, and no evidence of localized pneumonia, pulmonary emboli, congestive heart failure, or other identifiable lung diseases. In addition to ARDS, 4 patients developed progressive neurological (mental) changes, 3 developed fever, and 2 developed renal failure. Six patients were treated with ventilatory support in the ICU. Upon establishing the diagnosis of TTP, 6 patients were treated with exchange plasmapheresis (EP) and 1 patient with an infusion of fresh frozen plasma. Within 2 days of initiation of EP, 4 patients showed marked respiratory improvement; shortly thereafter, mechanical ventilation was ended. Complete and long-lasting remission was achieved in all 4 patients. Three patients died because of delayed diagnosis and untimely employment of EP.Conclusion:Life-threatening ARDS can be associated with TTP. It is recommended that all patients with ARDS and unexplained thrombocytopenia be evaluated for unrecognized TTP. Early recognition of ARDS associated with TTP and timely EP is critical to a favorable outcome.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
4. |
Poly-l-lysine-Based Molecular Conjugate Vectors:A High Efficiency Gene Transfer System for Human Progenitor and Leukemia Cells |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 129-136
Paul Schwarzenberger,
Weitao Huang,
Peter Oliver,
Tolu Osidipe,
Chris Theodossiou,
Jay Kolls,
Preview
|
PDF (161KB)
|
|
摘要:
Background:Targeted, specific receptor mediated gene transfer is a major goal of gene therapy research to accomplish gene transfer exclusively to the desired cell population.Methods:First, the use of natural receptor for stem cell factor and transferrin receptor-targeted gene transfer using poly-l-lysine–based molecular conjugate vectors was evaluated in a panel of hematopoietic progenitor cell lines. Second, the ability of poly-l-lysine to enhance adenovirus mediated gene transfer efficiency was examined in different cell lines by using recombinant adenovirus-poly-l-lysine molecular conjugate conglomerates (recMCVEGFP).Results:Despite effective ligand internalization receptor, gene expression amplification in receptor positive cell lines was not uniformly observed. Therefore, using a poly-l-lysine–based, receptor-targeted vector, neither transferrin nor natural receptor for stem cell factor mediated gene transfer can be considered a universally applicable procedure that exclusively depends on the presence of receptors on the cell surface; rather, it is a cell specific phenomenon. In our model, poly-l-lysine is the major contributor for gene transfer to hematopoietic progenitor cells, mediating the initial vector-cell binding. Human progenitor cell lines are poorly transduceable with recombinant adenovirus vectors. This new poly-l-lysine–modified, adenovirus-based vector could overcome virus tropism restrictions and consistently achieve very high transduction efficiency (>90%) in cells otherwise refractory to adenovirus gene transfer.Conclusions:Polylysine-based adenovirus vectors may have promise for situations in which high-efficiency gene transfer with transient high level transgene expression in hematopoietic cells is needed, such as leukemia vaccine protocols or for purging strategies in leukemia cell contaminated stem cell preparations.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
5. |
Adrenal Insufficiency in HIV Infection:A Review and Recommendations |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 137-144
Mohsen Saleh Eledrisi,
Abraham Verghese,
Preview
|
PDF (126KB)
|
|
摘要:
Adrenal insufficiency is known to be a complication of HIV infection, although estimates of its prevalence and severity vary. Adrenal insufficiency is the most serious endocrine complication that occurs in persons with HIV infection. Patients with acquired immune deficiency syndrome (AIDS) are considered to be at high risk for primary or secondary adrenal insufficiency. We describe 3 patients with AIDS who had clinical features suggestive of adrenal insufficiency, but their corticotropin (ACTH) stimulation tests were normal. Repeat testing confirmed the diagnosis in one patient, and further testing with the overnight metyrapone test revealed evidence of secondary adrenal insufficiency in the other patients. Persistent clinical improvement was evident on subsequent glucocorticoid therapy. A normal response to the ACTH stimulation test can be dangerously misleading. Patients with AIDS and suspected adrenal insufficiency who have normal screening by the ACTH stimulation test should undergo further testing for secondary adrenal disease.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
6. |
Prevention in Liver Disease |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 145-151
Miguel Arguedas,
Michael Fallon,
Preview
|
PDF (106KB)
|
|
摘要:
Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
7. |
The Role of Transesophageal Echocardiography in the Diagnosis and Management of Patients with Aortic Perivalvular Abscesses |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 152-155
Marschall Runge,
George Stouffer,
Richard Sheahan,
Stamatios Lerakis,
W. Robert Taylor,
Mary Lynch,
Craig Litman,
Stephen Clements,
Trevor Thompson,
Randolph Martin,
Preview
|
PDF (252KB)
|
|
摘要:
Aortic valve abscesses (AVAs) are a devastating complication of aortic valve endocarditis. Over 8 years, 25 patients were diagnosed with AVA by transesophageal echo (TEE). Management and outcomes were then analyzed. Eleven (44%) AVAs involved prosthetic valves, and 6 (24%) occurred in congenitally malformed valves. Twenty patients (80%) underwent surgical intervention; the rest were treated medically. Eleven (44%) of the patients died [6 (30%) surgery patients and all the medical patients]. Eight of 11 (73%) patients who died were culture positive forStaphylococcus aureus. All patients with congenitally malformed aortic valves underwent surgical intervention and survived. We conclude that: (1) despite advances in therapy and diagnosis, patients with AVAs have a high mortality rate; (2) prognosis with AVA is especially poor whenS aureusis the infectious organism; (3) patients with AVAs in congenitally malformed valves have a great outcome with surgery; (4) patients treated medically have a very poor prognosis; earlier identification by TEE may be critical to improving survival.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
8. |
A Case Report of Olanzapine-Induced Hypersensitivity Syndrome |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 156-158
Ayelet Raz,
Reuven Bergman,
Oron Eilam,
Tal Yungerman,
Tony Hayek,
Preview
|
PDF (253KB)
|
|
摘要:
Hypersensitivity syndrome is defined as a drug-induced complex of symptoms consisting of fever, rash, and internal organ involvement. The hypersensitivity syndrome is well recognized as being caused by anticonvulsants. Olanzapine is an atypical antipsychotic agent whose side effects include sedation, weight gain, and increased creatinine kinase and transaminase levels. To date, there have been no reports of hypersensitivity syndrome related to this drug. A 34-year-old man developed a severe generalized pruritic skin eruption, fever, eosinophilia, and toxic hepatitis 60 days after ingestion of olanzapine. After termination of olanzapine treatment, the fever resolved, the skin rash was reduced, eosinophil count was reduced to normal, and the transaminase levels were markedly reduced. Clinical features and the results of skin and liver biopsies indicated that the patient developed hypersensitivity syndrome caused by olanzapine.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
9. |
Severe Symptomatic Hyponatremia during Citalopram Therapy |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 159-160
Majed Odeh,
AHUVA Beny,
Arie Oliven,
Preview
|
PDF (77KB)
|
|
摘要:
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is an uncommon complication of treatment with the new class of antidepressant agents, the selective serotonin reuptake inhibitors (SSRIs). Most of the reported cases were associated with fluoxetine; only 2 have previously been described in association with citalopram. We describe an elderly woman who presented with severe symptomatic hyponatremia caused by the SIADH during therapy with citalopram. Because the use of SSRIs is becoming more popular among elderly depressed patients, the present case and the other 2 reported previously emphasize the need for greater awareness of the development of this serious and potentially fatal complication also in association with citalopram therapy and suggest that serum sodium levels should be monitored closely in elderly patients during treatment with citalopram.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
10. |
Erratum |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 2,
2001,
Page 161-161
Preview
|
|
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
|